{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T04:28:23Z","timestamp":1790483303733,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"13","license":[{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004895","name":"European Social Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004895","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1016\/j.clinbiochem.2011.06.006","type":"journal-article","created":{"date-parts":[[2011,6,26]],"date-time":"2011-06-26T00:26:44Z","timestamp":1309048004000},"page":"1137-1143","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Erythropoiesis versus inflammation in Hereditary Spherocytosis clinical outcome"],"prefix":"10.1016","volume":"44","author":[{"given":"Susana","family":"Rocha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"El\u00edsio","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petronila","family":"Rocha-Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F\u00e1tima","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esmeralda","family":"Cleto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Barbot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Quintanilha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu\u00eds","family":"Belo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Santos-Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinbiochem.2011.06.006_bb0005","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1365-2141.2004.05052.x","article-title":"Guidelines for the diagnosis and management of hereditary spherocytosis","volume":"126","author":"Bolton-Maggs","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clinbiochem.2011.06.006_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.blre.2006.03.005","article-title":"The molecular basis of hereditary red cell membrane disorders","volume":"21","author":"Delaunay","year":"2007","journal-title":"Blood Rev"},{"key":"10.1016\/j.clinbiochem.2011.06.006_bb0015","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/S0140-6736(08)61588-3","article-title":"Hereditary spherocytosis","volume":"372","author":"Perrotta","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.clinbiochem.2011.06.006_bb0020","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1182\/blood.V81.4.1067.1067","article-title":"Quantitative assessment of erythropoiesis and functional classification of anemia based on measurements of serum transferrin receptor and erythropoietin","volume":"81","author":"Beguin","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.clinbiochem.2011.06.006_bb0025","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1146\/annurev.me.44.020193.000431","article-title":"Serum transferrin receptor","volume":"44","author":"Cook","year":"1993","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.clinbiochem.2011.06.006_bb0030","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1007\/s00277-003-0623-3","article-title":"Diagnostic value of serum transferrin receptor and glycosylated hemoglobin on hemolytic anemia","volume":"82","author":"Ho","year":"2003","journal-title":"Ann Hematol"},{"key":"10.1016\/j.clinbiochem.2011.06.006_bb0035","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1046\/j.1365-2257.2001.00413.x","article-title":"Serum erythropoietin and its relation with soluble transferrin receptor in patients with different types of anaemia in a locally defined reference population","volume":"23","author":"Roque","year":"2001","journal-title":"Clin Lab Haematol"},{"key":"10.1016\/j.clinbiochem.2011.06.006_bb0040","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0009-8981(03)00005-6","article-title":"Soluble transferrin receptor for the evaluation of erythropoiesis and iron status","volume":"329","author":"Beguin","year":"2003","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.clinbiochem.2011.06.006_bb0045","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0002-9629(15)40630-5","article-title":"The measurement of serum transferrin receptor","volume":"318","author":"Cook","year":"1999","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.clinbiochem.2011.06.006_bb0050","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1111\/j.1651-2227.2000.tb00730.x","article-title":"Soluble transferrin receptor levels and soluble transferrin receptor\/log ferritin index in the evaluation of erythropoietic status in childhood infections and malignancy","volume":"89","author":"Dimitriou","year":"2000","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.clinbiochem.2011.06.006_bb0055","first-page":"72","article-title":"Serum transferrin receptor","volume":"838","author":"Skikne","year":"2008","journal-title":"Am J Hematol"},{"key":"10.1016\/j.clinbiochem.2011.06.006_bb0060","series-title":"Hematology in clinical practice third ed","first-page":"12","article-title":"Clinical approach to anemia","author":"Hillman","year":"2002"},{"key":"10.1016\/j.clinbiochem.2011.06.006_bb0065","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1046\/j.1365-2141.1996.00285.x","article-title":"Erythropoietin production and erythropoiesis in compensated and anaemic states of hereditary spherocytosis","volume":"92","author":"Guarnone","year":"1996","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clinbiochem.2011.06.006_bb0070","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1111\/j.1365-2141.2005.05802.x","article-title":"Erythropoietin levels in the different clinical forms of hereditary spherocytosis","volume":"131","author":"Rocha","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clinbiochem.2011.06.006_bb0075","doi-asserted-by":"crossref","first-page":"4142","DOI":"10.1182\/blood-2005-08-3364","article-title":"Dysregulated monocyte iron homeostasis and erythropoietin formation in patients with anemia of chronic disease","volume":"107","author":"Theurl","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.clinbiochem.2011.06.006_bb0080","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1515\/CCLM.2009.340","article-title":"Nucleated red blood cells and soluble transferrin receptor in thalassemia syndromes: relationship with global and ineffective erythropoiesis","volume":"47","author":"Danise","year":"2009","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.clinbiochem.2011.06.006_bb0085","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1600-0609.2008.01143.x","article-title":"Iron homeostasis: new players, newer insights","volume":"81","author":"Edison","year":"2008","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.clinbiochem.2011.06.006_bb0090","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s10741-008-9086-x","article-title":"Iron and anemia in human biology: a review of mechanisms","volume":"13","author":"Handelman","year":"2008","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.clinbiochem.2011.06.006_bb0095","doi-asserted-by":"crossref","first-page":"4617","DOI":"10.3748\/wjg.15.4617","article-title":"An update on iron physiology","volume":"15","author":"Munoz","year":"2009","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.clinbiochem.2011.06.006_bb0100","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1007\/s00508-006-0653-7","article-title":"Molecular and clinical aspects of iron homeostasis: from anemia to hemochromatosis","volume":"118","author":"Nairz","year":"2006","journal-title":"Wien Klin Wochenschr"},{"key":"10.1016\/j.clinbiochem.2011.06.006_bb0105","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1053\/beha.2002.0004","article-title":"Erythropoiesis and iron","volume":"15","author":"Cavill","year":"2002","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1016\/j.clinbiochem.2011.06.006_bb0110","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1093\/clinchem\/48.7.1066","article-title":"Biochemical markers and hematologic indices in the diagnosis of functional iron deficiency","volume":"48","author":"Thomas","year":"2002","journal-title":"Clin Chem"},{"key":"10.1016\/j.clinbiochem.2011.06.006_bb0115","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1097\/01.ASN.0000071514.36428.61","article-title":"Increased expression of erythropoiesis inhibiting cytokines (IFN-gamma, TNF-alpha, IL-10, and IL-13) by T cells in patients exhibiting a poor response to erythropoietin therapy","volume":"14","author":"Cooper","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.clinbiochem.2011.06.006_bb0120","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1600-0609.2007.00818.x","article-title":"Erythropoietin after a century of research: younger than ever","volume":"78","author":"Jelkmann","year":"2007","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.clinbiochem.2011.06.006_bb0125","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1046\/j.1365-2257.2001.00351.x","article-title":"Erythropoietin","volume":"23","author":"Kendall","year":"2001","journal-title":"Clin Lab Haematol"},{"issue":"Suppl 11","key":"10.1016\/j.clinbiochem.2011.06.006_bb0130","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/ndt\/17.suppl_11.39","article-title":"Erythropoietin resistance: the role of inflammation and pro-inflammatory cytokines","volume":"17","author":"Macdougall","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.clinbiochem.2011.06.006_bb0135","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1182\/blood.V80.7.1639.1639","article-title":"Progress in understanding the pathogenesis of the anemia of chronic disease","volume":"80","author":"Means","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.clinbiochem.2011.06.006_bb0140","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1002\/hep.1840180420","article-title":"Regulation of iron metabolism in HepG2 cells: a possible role for cytokines in the hepatic deposition of iron","volume":"18","author":"Hirayama","year":"1993","journal-title":"Hepatology"},{"key":"10.1016\/j.clinbiochem.2011.06.006_bb0145","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0020-1693(02)01049-6","article-title":"Iron and iron proteins found in the genetic disease, hereditary spherocytosis","volume":"339","author":"Meyrick","year":"2002","journal-title":"Inorg Chim Acta"},{"key":"10.1016\/j.clinbiochem.2011.06.006_bb0150","series-title":"Dacie and Lewis practical haematology","first-page":"199","article-title":"Acquired haemolytic anaemias","author":"Regan","year":"2001"},{"key":"10.1016\/j.clinbiochem.2011.06.006_bb0155","first-page":"707","article-title":"I.C.S.H. reference method for staining of blood and bone marrow films by azure B and eosin Y (Romanowsky stain)","volume":"57","author":"I.C.S.H.","year":"1984","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clinbiochem.2011.06.006_bb0160","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1159\/000121478","article-title":"Role of prohepcidin, inflammatory markers and iron status in resistance to rhEPO therapy in hemodialysis patients","volume":"28","author":"Costa","year":"2008","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.clinbiochem.2011.06.006_bb0165","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1111\/j.1365-2141.2010.08166.x","article-title":"Erythrocyte membrane protein destabilization versus clinical outcome in 160 Portuguese Hereditary Spherocytosis patients","volume":"149","author":"Rocha","year":"2010","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clinbiochem.2011.06.006_bb0170","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.exphem.2007.01.026","article-title":"Erythropoietin and iron-restricted erythropoiesis","volume":"35","author":"Goodnough","year":"2007","journal-title":"Exp Hematol"},{"key":"10.1016\/j.clinbiochem.2011.06.006_bb0175","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1182\/blood.V96.3.823","article-title":"Erythropoietin, iron, and erythropoiesis","volume":"96","author":"Goodnough","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.clinbiochem.2011.06.006_bb0180","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.bcmd.2010.11.001","article-title":"Complementary markers for the clinical severity classification of hereditary spherocytosis in unsplenectomized patients","volume":"46","author":"Rocha","year":"2011","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.clinbiochem.2011.06.006_bb0185","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.dci.2003.09.010","article-title":"Regulation of myeloid development and function by colony stimulating factors","volume":"28","author":"Barreda","year":"2004","journal-title":"Dev Comp Immunol"},{"key":"10.1016\/j.clinbiochem.2011.06.006_bb0190","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1471-2121-5-39","article-title":"Production of hemo- and immunoregulatory cytokines by erythroblast antigen+and glycophorin A+cells from human bone marrow","volume":"5","author":"Sennikov","year":"2004","journal-title":"BMC Cell Biol"},{"key":"10.1016\/j.clinbiochem.2011.06.006_bb0195","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s10719-006-7928-0","article-title":"Role of C-reactive protein in complement-mediated hemolysis in Malaria","volume":"23","author":"Ansar","year":"2006","journal-title":"Glycoconj J"},{"key":"10.1016\/j.clinbiochem.2011.06.006_bb0200","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1159\/000204106","article-title":"Unraveling the C-reactive protein complement-cascade in destruction of red blood cells: potential pathological implications in Plasmodium falciparum malaria","volume":"23","author":"Ansar","year":"2009","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.clinbiochem.2011.06.006_bb0205","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1007\/s10719-009-9236-y","article-title":"Disease-associated glycosylated molecular variants of human C-reactive protein activate complement-mediated hemolysis of erythrocytes in tuberculosis and Indian visceral leishmaniasis","volume":"26","author":"Ansar","year":"2009","journal-title":"Glycoconj J"}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912011004152?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912011004152?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T20:08:08Z","timestamp":1762114088000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912011004152"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":41,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["S0009912011004152"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2011.06.006","relation":{},"ISSN":["0009-9120"],"issn-type":[{"value":"0009-9120","type":"print"}],"subject":[],"published":{"date-parts":[[2011,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Erythropoiesis versus inflammation in Hereditary Spherocytosis clinical outcome","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2011.06.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}